JDRF Blog

Latest in Research

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • JDRF’s One Night: The Power of Us Is Unstoppable

    June 23, 2020

    One Night. One Community. One Purpose: to show the world the undeniable power of people living with T1D.

  • Tandem Control-IQ—Now Authorized For Children

    June 17, 2020

    Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology in children ages six and older.

  • University of Michigan Establishes Elizabeth Weiser Caswell Diabetes Institute

    June 15, 2020

    Named for JDRF Research Committee member Elizabeth Caswell, Institute will support diabetes research and development of life-changing diabetes therapies.

  • JDRF Top Advances Over the Past Year

    June 9, 2020

    At JDRF, we are committed to funding the development of new therapies to keep people with type 1 diabetes (T1D) healthier, longer,...

  • From the Archives: Mapping Directions for Diabetes Research

    June 3, 2020

    A historical account about a past initiative that would help pave the way for JDRF’s future approach to identifying research priorities.

  • Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study

    May 28, 2020

    Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.